Table 3 The meta-analytic BF for Alzheimer’s disease.

From: Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer’s and Parkinson’s diseases

DTI-ALPS

\(lo{g}_{10}\)(BF20)

Median effect

Whole-brain

10

0.53

Left hemisphere

6.57

0.51

Right hemisphere

3.42

0.47

  1. Each row represents a measured condition. All means the whole brain DTI-ALPS. Left and Right are the DTI-ALPS measured in the two sides of the brain. Results are expressed as the \(lo{g}_{10}\), that is the logarithm of the Bayes factor which measures the strength of the evidence of the measured effect size. The last column is the dimension of the effect for the different pathologies is also provided and measured in the whole and lateralized brain.
Back to article page